Jan 17 2025 This Week in Cardiology


Episode Artwork
1.0x
0% played 00:00 00:00
Jan 17 2025 31 mins   88

Renal denervation, the obesity paradox, JACC and the FINEARTS trial of finerenone in HFpEF, a setback for a PFA system, and coffee are the topics Jon Mandrola, MD, covers this week.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. RDN

  • CMS https://www.cms.gov/medicare-coverage-database/view/ncacal-tracking-sheet.aspx?ncaid=318
  • Messerli https://doi.org/10.1016/j.jacc.2024.09.1244
  • Filippone https://doi.org/10.1016/j.amjmed.2023.05.010

II. Finerenone

  • FINEHEARTS -HF NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2407107
  • FIDELIO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2025845
  • FIGARO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2110956
  • Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF? https://doi.org/10.1016/j.jacc.2024.08.033
  • Regional Variation TOPCAT https://www.ahajournals.org/doi/10.1161/circulationaha.114.013255
  • Time from WHF Subanalysis https://doi.org/10.1016/j.jacc.2024.09.004
  • REDEFINE - https://clinicaltrials.gov/study/NCT06008197
  • Health status paper https://doi.org/10.1016/j.jacc.2024.09.023
  • Obesity subanalysis https://doi.org/10.1016/j.jacc.2024.10.111
  • Kidney outcomes https://www.sciencedirect.com/science/article/pii/S0735109724102525
  • Kidney outcomes 2 https://doi.org/10.1016/j.jacc.2024.11.020
  • Kaul editorial https://doi.org/10.1016/j.jacc.2024.11.024

III. PFA Setback

J&J Halts Varipulse Field Ablation for AFib

https://www.medscape.com/viewarticle/j-j-halts-varipulse-field-ablation-afib-2025a10000j8

IV. Coffee

Stop the Coffee Studies https://www.medscape.com/viewarticle/883709

  • Coffee drinking timing and mortality in US adults

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact [email protected]